Primary Site >> Liver Cancer

Gene >> FGF21

  • 2006
  • 2008
  • 2010
  • 2011
  • 2012
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
PMID: 16929488
Ref: Mini-review: endocrine actions of fibroblast growth factor 19.
PMID: 18179175
Ref: FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
PMID: 20018895
Ref: Thiazolidinediones are potent inducers of fibroblast growth factor 21 expression in the liver.
PMID: 21720023
Ref: Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities.
PMID: 22396171
Ref: Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21.
PMID: 25082895
Ref: Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice.
PMID: 25234947
Ref: Forced expression of fibroblast growth factor 21 reverses the sustained impairment of liver regeneration in hPPARalpha(PAC) mice due to dysregulated bile acid synthesis.
PMID: 25991671
Ref: Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis.
PMID: 26121037
Ref: Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation.
PMID: 26175944
Ref: Mapping the response of human fibroblast growth factor 21 (FGF21) promoter to serum availability and lipoic acid in HepG2 hepatoma cells.
PMID: 26691139
Ref: Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and Disease.
PMID: 27148532
Ref: Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice.
PMID: 27293995
Ref: Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy.
PMID: 28334808
Ref: Amelioration of late-onset hepatic steatosis in IDH2-deficient mice.
PMID: 28415887
Ref: Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma.
PMID: 28445152
Ref: Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases.
PMID: 29184085
Ref: Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet.
PMID: 29753678